Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetics and safety of fidaxomicin in patients with inflammatory bowel disease and Clostridium difficile infection: an open-label Phase IIIb/IV study (PROFILE).
Högenauer C, Mahida Y, Stallmach A, Marteau P, Rydzewska G, Ivashkin V, Gargalianos-Kakolyris P, Michon I, Adomakoh N, Georgopali A, Tretter R, Karas A, Reinisch W. Högenauer C, et al. J Antimicrob Chemother. 2018 Dec 1;73(12):3430-3441. doi: 10.1093/jac/dky368. J Antimicrob Chemother. 2018. PMID: 30260412 Clinical Trial.
Consensus report: faecal microbiota transfer - clinical applications and procedures.
König J, Siebenhaar A, Högenauer C, Arkkila P, Nieuwdorp M, Norén T, Ponsioen CY, Rosien U, Rossen NG, Satokari R, Stallmach A, de Vos W, Keller J, Brummer RJ. König J, et al. Among authors: hogenauer c. Aliment Pharmacol Ther. 2017 Jan;45(2):222-239. doi: 10.1111/apt.13868. Epub 2016 Nov 27. Aliment Pharmacol Ther. 2017. PMID: 27891639 Free PMC article. Review.
[Ustekinumab - Current position].
Siegmund B, Högenauer C, Novacek G, Petritsch W, Reinisch W, Schoepfer A, Schreiber S, Vavricka S, Bokemeyer B; für die IBD-Dach-Gruppe. Siegmund B, et al. Among authors: hogenauer c. Z Gastroenterol. 2018 Sep;56(9):1077-1086. doi: 10.1055/a-0655-2425. Epub 2018 Aug 13. Z Gastroenterol. 2018. PMID: 30103222 Review. German.
Tofacitinib in the treatment of ulcerative colitis : A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH).
Kutschera M, Novacek G, Reinisch W, Högenauer C, Petritsch W, Haas T, Moschen A, Dejaco C. Kutschera M, et al. Among authors: hogenauer c. Wien Klin Wochenschr. 2023 Jan;135(1-2):1-13. doi: 10.1007/s00508-022-02110-2. Epub 2022 Dec 1. Wien Klin Wochenschr. 2023. PMID: 36454302 Free PMC article.
[Probiotics for the prevention of antibiotic-induced diarrhea].
Eser A, Thalhammer F, Burghuber F, Högenauer C, Stockenhuber F, Wenisch C, Widhalm K, Reinisch W. Eser A, et al. Among authors: hogenauer c. Z Gastroenterol. 2012 Oct;50(10):1089-95. doi: 10.1055/s-0032-1312950. Epub 2012 Oct 11. Z Gastroenterol. 2012. PMID: 23059802 German.
[Second Austrian consensus on the safe use of anti-TNFα-antibodies in patients with inflammatory bowel diseases].
Miehsler W, Dejaco C, Gröchenig HP, Fuchssteiner H, Högenauer C, Kazemi-Shirazi L, Maier H, Mayer A, Moschen A, Reinisch W, Petritsch W, Platzer R, Steiner P, Tilg H, Vogelsang H, Wenzl H, Novacek G. Miehsler W, et al. Among authors: hogenauer c. Z Gastroenterol. 2018 Mar;56(3):275-302. doi: 10.1055/s-0044-100044. Epub 2018 Mar 12. Z Gastroenterol. 2018. PMID: 29529682 German.
Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial.
Blesl A, Borenich A, Gröchenig HP, Novacek G, Primas C, Reinisch W, Kutschera M, Illiasch C, Hennlich B, Steiner P, Koch R, Tillinger W, Haas T, Reicht G, Mayer A, Ludwiczek O, Miehsler W, Steidl K, Binder L, Baumann-Durchschein F, Fürst S, Reider S, Watschinger C, Wenzl H, Moschen A, Berghold A, Högenauer C; Austrian IBD Study Group (ATISG). Blesl A, et al. Among authors: hogenauer c. J Clin Med. 2023 Jul 24;12(14):4853. doi: 10.3390/jcm12144853. J Clin Med. 2023. PMID: 37510968 Free PMC article.
120 results